About US
Contact us
-
BASF increases prices for ethanolamines in EuropeBASF increases prices for ethanolamines in Europe With immediate effect, or as existing contracts permit, BASF is increasing its European sales prices for ethanolamines (EOA) as follows:2010/11/2
-
Pfizer announces approval of Lyrica capsules for peripheral neuropathic painPfizer announces approval of Lyrica capsules for peripheral neuropathic pain Pfizer Inc.(NYSE: PFE) announced today that the Japanese Ministry of Health, Labour and Welfare approved Lyrica® (p2010/11/1
-
DuoCort Pharma and Recipharm start innovative collaborationDuoCort Pharma and Recipharm start innovative collaboration DuoCort Pharma announces it has concluded an agreement with Recipharm under which Recipharm is set to scale-up the manufacturing of Duo2010/11/1
-
Specification on Technical Requirements for Health Food Products issuedSpecification on Technical Requirements for Health Food Products issued In accordance with the Food Safety Law and its implementation regulations, the State Food and Drug Administration (SFDA) rec2010/10/29
-
SFDA Deputy Commissioner Wu Zhen attends the 4th Joint ChP-USP International SymposiumSFDA Deputy Commissioner Wu Zhen attends the 4th Joint ChP-USP International Symposium On October 21-22, 2010, the 4th Joint ChP-USP International Symposium cosponsored by the Chinese Pharmacopeia2010/10/29
-
Pfizer's Sutent stands as first-line setting for treating renal cell carcinoma: SurveyPfizer's Sutent stands as first-line setting for treating renal cell carcinoma: Survey Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare2010/10/28
-
US FDA cracks down on importation of unapproved new drugs for personal useUS FDA cracks down on importation of unapproved new drugs for personal use The United States Food and Drug Administration (“FDA”) is cracking down on the importation of unapproved new drugs with r2010/10/28
-
Pharmacopeias of US and Kazakhstan sign accordPharmacopeias of US and Kazakhstan sign accord With the mutual goal of improving the quality of pharmaceuticals worldwide, the United States Pharmacopeial Convention (USP) and the Republican State2010/10/27
-
PAREXEL's white paper provides data on biopharmaceutical, medical device product developmentPAREXEL's white paper provides data on biopharmaceutical, medical device product development PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL) and a leading global life s2010/10/27
-
Essentialis, FDA enter agreement on SPA for DCCR Phase 3 efficacy study in patients with high triglyceridesEssentialis, FDA enter agreement on SPA for DCCR Phase 3 efficacy study in patients with high triglycerides Essentialis, Inc. announced today that the company has reached agreement with the U.S. F2010/10/26